Function and glycosylation of plant-derived antiviral monoclonal antibody
AUTOR(ES)
Ko, Kisung
FONTE
National Academy of Sciences
RESUMO
Plant genetic engineering led to the production of plant-derived mAb (mAbP), which provides a safe and economically feasible alternative to the current methods of antibody production in animal systems. In this study, the heavy and light chains of human anti-rabies mAb were expressed and assembled in planta under the control of two strong constitutive promoters. An alfalfa mosaic virus untranslated leader sequence and Lys-Asp-Glu-Leu (KDEL) endoplasmic reticulum retention signal were linked at the N and C terminus of the heavy chain, respectively. mAbP was as effective at neutralizing the activity of the rabies virus as the mammalian-derived antibody (mAbM) or human rabies Ig (HRIG). The mAbP contained mainly oligomannose type N-glycans (90%) and had no potentially antigenic α(1,3)-linked fucose residues. mAbP had a shorter half-life than mAbM. The mAbP was as efficient as HRIG for post-exposure prophylaxis against rabies virus in hamsters, indicating that differences in N-glycosylation do not affect the efficacy of the antibody in this model.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164704Documentos Relacionados
- Immunization against rabies with plant-derived antigen
- Immunogenicity of transgenic plant-derived hepatitis B surface antigen.
- Plant-Derived Oils Reduce Pathogens and Gaseous Emissions from Stored Cattle Waste
- Plant-derived antimalarial agents: new leads and efficient phythomedicines. Part I. Alkaloids
- Different susceptibilities of Aedes aegypti and Aedes albopictus larvae to plant-derived products